Hematology / Oncology CME Courses
The following CME/CE courses are available for credit on myCME. Simply click on any link below to get started.
This activity will increase the ability of hematology and oncology clinicians to incorporate the latest research and treatment recommendations for progressive or relapsed MM into their clinical practice, thus ensuring the best possible outcomes for each patient.
This activity offers:
1.00 / AMA PRA Category 1 CreditTM
Sign Up for Free e-newsletters
Breast Cancer Awareness Month Poll
Cancer Therapy Advisor Articles
- Will Epigenetic Drugs Improve Immunotherapy Outcomes?
- Preoperative Breast MRI Associated With Longer Wait Time to Surgery
- Quitting Smoking Prior to Chemo Linked to Improved Survival Rate in Stage 4 Lung Cancer
- PD-L1 May Predict Response to TKIs, VEGFs in Metastatic Clear Cell Renal Cell Carcinoma
- Hyper-CVAD Plus Ponatinib May Be Effective for Newly Diagnosed Ph+ Acute Leukemia
- Olaparib Plus Paclitaxel Active in Metastatic Gastric Cancer
- For Metastatic Gastric Cancer, Modified DCF Should Be First-Line Option
- Routine CT Scans for B-cell Lymphoma Patients in Complete Remission Not Recommended
- Viral MicroRNA Expression Linked to Worse Clinical Outcomes in Early Stage Malignancies
- Prognostic Markers for Survival in Mycosis Fundoides, Sézary Syndrome Identified
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|